Skip to content

Effects of repeated transcranial magnetic stimulation on balance and gait in patients with residual dizziness after reduction of benign paroxysmal positional vertigo

Effects of repeated transcranial magnetic stimulation on balance and gait in patients with residual dizziness after reduction of benign paroxysmal positional vertigo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076755
Enrollment
Unknown
Registered
2023-10-17
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign paroxysmal positional vertigo

Interventions

Intervention group:After successful manual reduction, the intervention group used rTMS to stimulate the left dorsolateral prefrontal lobe (L-DLPFC) area for 1 week, once a day for a total of 5 times,
Control group:After successful manual reduction, no medications or specific interventions are given.

Sponsors

The First Affiliated Hospital of the Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) The diagnostic criteria for benign paroxysmal positional vertigo (BPPV) were adopted according to the diagnostic criteria formulated by the International Barany Society in 2015 (von Brevern M, et al. J Vestib Res. 2015; 25(3-4) : 105-17.) (2) All patients received manual reduction treatment and met the successful reduction criteria. (3) Patients with successful BPPV reduction treatment were evaluated for residual dizziness the next day after reduction. (4) No mental illness, acute cerebrovascular disease, able to understand and follow the research protocol. (5) Patients and their families are aware of this study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Multi-tube or upper tube BPPV. (2) otolith manual reduction treatment failed. (3) Combined with other vestibular diseases, such as vestibular neuritis, vestibular migraine, etc. (4) acute cerebrovascular diseases, neurodegenerative diseases, etc. (5) Contraindications of MRI examination. (6) Contraindications for rTMS treatment. (7) Refuse to participate in the test. (8) Patients with disability, dementia and walking impairment.

Design outcomes

Primary

MeasureTime frame
Dizziness Handicap Inventory;Visual analogue scale;

Secondary

MeasureTime frame
Balance function test (Berg balance scale, closed eyes difficult test);Gait function assessment (timed stand-up-walk test);

Countries

CHINA

Contacts

Public ContactBaiYa

The First Affiliated Hospital of the Air Force Medical University

xiabing616@163.com+86 186 2952 8468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026